Molecular Profiling of the Residual Disease of Triple-Negative Breast Cancers after Neoadjuvant Chemotherapy Identifies Actionable Therapeutic Targets-Reference-Cited by-同舟云学术

Molecular Profiling of the Residual Disease of Triple-Negative Breast Cancers after Neoadjuvant Chemotherapy Identifies Actionable Therapeutic Targets

Published:2013-12-19 Issue:2 Volume:4 Page:232-245
ISSN:2159-8274
Container-title:Cancer Discovery
language:en
Short-container-title:Cancer Discovery

Author:

Balko Justin M.,Giltnane Jennifer M.,Wang Kai,Schwarz Luis J.,Young Christian D.,Cook Rebecca S.,Owens Phillip,Sanders Melinda E.,Kuba Maria G.,Sánchez Violeta,Kurupi Richard,Moore Preston D.,Pinto Joseph A.,Doimi Franco D.,Gómez Henry,Horiuchi Dai,Goga Andrei,Lehmann Brian D.,Bauer Joshua A.,Pietenpol Jennifer A.,Ross Jeffrey S.,Palmer Gary A.,Yelensky Roman,Cronin Maureen,Miller Vincent A.,Stephens Phillip J.,Arteaga Carlos L.

Publisher

American Association for Cancer Research (AACR)

Subject

Oncology

Cited by 409 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. CDK9 inhibitors for the treatment of solid tumors;Biochemical Pharmacology;2024-11

2. Mitochondrial bioenergetics of breast cancer;Mitochondrion;2024-11

3. Unveiling the Mechanisms of Apoptosis Induction by Deep‐Sea‐Derived Polyketide‐Terpenoid Hybrids from Penicillium allii‐sativi: A Focus on Mitochondrial and mTOR Pathways;Chinese Journal of Chemistry;2024-08-26

4. Dual inhibition of the TrkA and JAK2 pathways using entrectinib and pacritinib suppresses the growth and metastasis of HER2-positive and triple-negative breast cancers;Cancer Letters;2024-08

5. Enhanced expression of galectin‐9 in triple negative breast cancer cells following radiotherapy: Implications for targeted therapy;International Journal of Cancer;2024-07-30